Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 3
2016 2
2017 4
2018 3
2020 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean virginia baylor (2,667 results)?
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW. Casey SC, et al. Among authors: baylot v. Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10. Science. 2016. PMID: 26966191 Free PMC article.
MYC: Master Regulator of Immune Privilege.
Casey SC, Baylot V, Felsher DW. Casey SC, et al. Among authors: baylot v. Trends Immunol. 2017 Apr;38(4):298-305. doi: 10.1016/j.it.2017.01.002. Epub 2017 Feb 21. Trends Immunol. 2017. PMID: 28233639 Free PMC article. Review.
TCTP as therapeutic target in cancers.
Acunzo J, Baylot V, So A, Rocchi P. Acunzo J, et al. Among authors: baylot v. Cancer Treat Rev. 2014 Jul;40(6):760-9. doi: 10.1016/j.ctrv.2014.02.007. Epub 2014 Mar 2. Cancer Treat Rev. 2014. PMID: 24650927 Review.
Hsp27 as a therapeutic target in cancers.
Acunzo J, Andrieu C, Baylot V, So A, Rocchi P. Acunzo J, et al. Among authors: baylot v. Curr Drug Targets. 2014 Apr;15(4):423-31. doi: 10.2174/13894501113146660230. Curr Drug Targets. 2014. PMID: 24138636 Review.
The MYC oncogene is a global regulator of the immune response.
Casey SC, Baylot V, Felsher DW. Casey SC, et al. Among authors: baylot v. Blood. 2018 May 3;131(18):2007-2015. doi: 10.1182/blood-2017-11-742577. Epub 2018 Mar 7. Blood. 2018. PMID: 29514782 Free PMC article. Review.
TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling.
Amson R, Senff-Ribeiro A, Karafin T, Lespagnol A, Honoré J, Baylot V, Banroques J, Tanner NK, Chamond N, Dimitrov JD, Hoebeke J, Droin NM, Job B, Piard J, Bommer UA, Choi KW, Abdelfatah S, Efferth T, Telerman SB, Geyer FC, Reis-Filho J, Telerman A. Amson R, et al. Among authors: baylot v. EMBO Rep. 2024 Apr;25(4):1962-1986. doi: 10.1038/s44319-024-00108-7. Epub 2024 Mar 28. EMBO Rep. 2024. PMID: 38548973 Free PMC article.
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
Dhanasekaran R, Gabay-Ryan M, Baylot V, Lai I, Mosley A, Huang X, Zabludoff S, Li J, Kaimal V, Karmali P, Felsher DW. Dhanasekaran R, et al. Among authors: baylot v. Oncotarget. 2017 Nov 9;9(5):5517-5528. doi: 10.18632/oncotarget.22342. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464015 Free PMC article.
18 results